Allakos, Bay Area biotech firm based in San Carlos, is laying off 75% of its staff and eyeing a shutdown after its clinical ...
Allakos is throwing in the towel. After seeing phase 1 data in hives, the biotech has decided to drop the drug candidate and ...
A year after reducing half of its workforce, Allakos will downsize to just 15 employees as it halts the development of AK006.
A teenager with more than 40 allergies has told how she uses a colour-coded spread sheet to keep track of them all. From ...
GlobalData on MSN3d
Alys Pharmaceuticals receives regulatory approvals for alopaecia areata drug trialAlys Pharmaceuticals has received clearance from the US FDA and Health Canada for a Phase IIa trial of ALY-101 for alopaecia ...
It was the best of biotech times, it was the worst of biotech times: One company soars, another stumbles and a third outlines ...
Allakos has announced a 75% workforce reduction and the discontinuation of its chronic spontaneous urticaria (CSU) AK006 development programme following underwhelming Phase I results. This ...
New allergies frequently pop up and their severities can change too – meaning Chloe has to keep track of them with a color-coded spreadsheet.
A woman who is living with over 40 allergies, including water, has shared how she has to use a colour-coded spread sheet to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback